• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dose-dependent elimination of propranolol and its major metabolites in humans.

作者信息

Silber B M, Holford N H, Riegelman S

出版信息

J Pharm Sci. 1983 Jul;72(7):725-32. doi: 10.1002/jps.2600720703.

DOI:10.1002/jps.2600720703
PMID:6886977
Abstract
摘要

相似文献

1
Dose-dependent elimination of propranolol and its major metabolites in humans.
J Pharm Sci. 1983 Jul;72(7):725-32. doi: 10.1002/jps.2600720703.
2
Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma.
Ther Drug Monit. 1983;5(1):87-93. doi: 10.1097/00007691-198303000-00008.
3
Pharmacokinetics of glucuronidation of propranolol following oral administration in humans.
Biopharm Drug Dispos. 1983 Oct-Dec;4(4):331-8. doi: 10.1002/bdd.2510040405.
4
Presystemic and systemic glucuronidation of propranolol.
Clin Pharmacol Ther. 1979 Aug;26(2):167-72. doi: 10.1002/cpt1979262167.
5
Stereoselective disposition and glucuronidation of propranolol in humans.普萘洛尔在人体内的立体选择性分布及葡萄糖醛酸化作用。
J Pharm Sci. 1982 Jun;71(6):699-704. doi: 10.1002/jps.2600710623.
6
Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity.
J Pharmacol Exp Ther. 1982 Aug;222(2):458-62.
7
Theoretical Michaelis-Menten elimination model for propranolol.普萘洛尔的理论米氏消除模型。
Eur J Drug Metab Pharmacokinet. 1985 Jul-Sep;10(3):241-5. doi: 10.1007/BF03189748.
8
Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranolol.长期普萘洛尔治疗期间普萘洛尔葡萄糖醛酸苷的蓄积：一种关于普萘洛尔的潜在储存机制
Clin Pharmacol Ther. 1979 Dec;26(6):686-95. doi: 10.1002/cpt1979266686.
9
Effects of acute alcohol administration on propranolol absorption.急性酒精摄入对普萘洛尔吸收的影响。
Int J Clin Pharmacol Ther Toxicol. 1980 Jul;18(7):317-9.
10
Analysis and disposition of low dose oral propranolol.低剂量口服普萘洛尔的分析与处置
Res Commun Chem Pathol Pharmacol. 1978 Jun;20(3):531-8.

引用本文的文献

1
Application of gastrointestinal simulation for extensions for biowaivers of highly permeable compounds.胃肠道模拟在高渗透性化合物生物豁免扩展中的应用。
AAPS J. 2008;10(1):213-26. doi: 10.1208/s12248-008-9023-x. Epub 2008 Apr 2.
2
Time-dependent inhibition of human drug metabolizing cytochromes P450 by tricyclic antidepressants.三环类抗抑郁药对人药物代谢细胞色素P450的时间依赖性抑制作用。
Br J Clin Pharmacol. 2008 Jan;65(1):87-97. doi: 10.1111/j.1365-2125.2007.02964.x. Epub 2007 Jul 27.
3
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.
PKQuest：一种基于生理学的通用药代动力学模型。普萘洛尔的介绍与应用
BMC Clin Pharmacol. 2002 Aug 15;2:5. doi: 10.1186/1472-6904-2-5.
4
Clinical significance of genetic influences on cardiovascular drug metabolism.基因对心血管药物代谢影响的临床意义。
Cardiovasc Drugs Ther. 1993 Jun;7(3):311-24. doi: 10.1007/BF00880154.
5
Accumulation kinetics of propranolol in the rat: comparison of Michaelis-Menten-mediated clearance and clearance changes consistent with the "altered enzyme hypothesis".普萘洛尔在大鼠体内的蓄积动力学：米氏介导清除率与符合“酶改变假说”的清除率变化的比较
Pharm Res. 1994 Mar;11(3):420-5. doi: 10.1023/a:1018921306200.
6
The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol.异喹胍氧化表型与普萘洛尔的药代动力学和药效学之间的关系。
Br J Clin Pharmacol. 1984 Jun;17(6):679-85. doi: 10.1111/j.1365-2125.1984.tb02403.x.
7
Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.门腔静脉转位术后犬体内普萘洛尔代谢产物的非线性形成。
J Pharmacokinet Biopharm. 1984 Aug;12(4):401-12. doi: 10.1007/BF01062665.
8
Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.茶碱。米氏参数汇总（最大反应速度Vmax和米氏常数Km）及其意义。
Clin Pharmacokinet. 1985 Sep-Oct;10(5):432-42. doi: 10.2165/00003088-198510050-00005.
9
Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-state.
Eur J Clin Pharmacol. 1987;33(3):315-8. doi: 10.1007/BF00637569.
10
Nonlinear pharmacokinetics: clinical Implications.非线性药代动力学：临床意义。
Clin Pharmacokinet. 1991 Jun;20(6):429-46. doi: 10.2165/00003088-199120060-00001.